Obeda 7mg is an oral semaglutide preparation intended for continued diabetes management after appropriate dose escalation. Its GLP-1 receptor activity helps improve glucose-dependent insulin secretion and suppress excess glucagon release.

The medicine can also slow the movement of food from the stomach and influence appetite. These combined effects support improved glycemic control when used with appropriate diet and physical activity.

Brand: Obeda

Active Ingredient: Semaglutide 7mg

Dosage Form: Tablet

Strength: 7mg

Drug Class: GLP-1 receptor agonist

Route: Oral

Use according to the prescribed regimen and administration instructions.